Delivery Pathway Regulation of 3',3"-Bis-Peptide-siRNA Conjugate via Nanocarrier Architecture Engineering
Small interfering RNA (siRNA) has been continuously explored for clinical applications. However, neither nanocarriers nor conjugates have been able to remove the obstacles. In this study, we employed a combined nanochemistry strategy to optimize its delivery dilemma, where different interactions and...
Gorde:
Egile Nagusiak: | , , , , , , , , |
---|---|
Formatua: | Liburua |
Argitaratua: |
Elsevier,
2018-03-01T00:00:00Z.
|
Gaiak: | |
Sarrera elektronikoa: | Connect to this object online. |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Internet
Connect to this object online.3rd Floor Main Library
Sailkapena: |
A1234.567 |
---|---|
Alea 1 | Eskuragarri |